Glycated hemoglobin and outcomes of patients with acute ischemic stroke
10.3760/cma.j.issn.1673-4165.2021.10.008
- VernacularTitle:糖化血红蛋白与急性缺血性卒中患者转归
- Author:
Yanyu HU
1
;
Xiao CHEN
;
Ling ZHOU
Author Information
1. 衡水市人民医院心内科 053000
- Keywords:
Stroke;
Brain ischemia;
Glycated hemoglobin A;
Treatment outcome;
Diabetes mellitus;
Biomarkers
- From:
International Journal of Cerebrovascular Diseases
2021;29(10):765-769
- CountryChina
- Language:Chinese
-
Abstract:
Diabetes is an important risk factor for ischemic stroke. The glycated hemoglobin (HbA1c) level reflects the mean blood glucose level in the past 8-12 weeks. It is a detection index of abnormal glucose metabolism and chronic hyperglycemia. Some studies have shown that high HbA1c is associated with the poor outcomes of patients with acute ischemic stroke, including patients treated with intravenous thrombolysis and endovascular mechanical thrombectomy. This article reviews the relationship between HbA1c and the outcomes of patients with acute ischemic stroke.
